Showing results (1-10 of 43) with videos related to
Sort By:
Pageof 5
Neural Regeneration Research|February 16, 2017
Can cannabinoids be a potential therapeutic tool in amyotrophic lateral sclerosis?Sabrina Giacoppo, Emanuela MazzonArchivum Immunologiae Et Therapiae Experimentalis|March 26, 2017
The transplantation of mesenchymal stem cells derived from unconventional sources: an innovative approach to multiple sclerosis therapySabrina Giacoppo, Placido Bramanti, Emanuela MazzonNeuroreport|September 14, 2017
Triggering of inflammasome by impaired autophagy in response to acute experimental Parkinson's disease: involvement of the PI3K/Akt/mTOR pathwaySabrina Giacoppo, Placido Bramanti, Emanuela MazzonMultiple Sclerosis and Related Disorders|October 23, 2017
Sativex in the management of multiple sclerosis-related spasticity: An overview of the last decade of clinical evaluationSabrina Giacoppo, Placido Bramanti, Emanuela MazzonMolecules (Basel, Switzerland)|March 8, 2014
Use of natural compounds in the management of diabetic peripheral neuropathyMaria Galuppo, Sabrina Giacoppo, Placido Bramanti, et al.Molecular Pain|July 26, 2017
Topical moringin-cream relieves neuropathic pain by suppression of inflammatory pathway and voltage-gated ion channels in murine model of multiple sclerosisSabrina Giacoppo, Renato Iori, Placido Bramanti, et al.Inflammation|September 23, 2017
NLRP3 Inflammasome Activation in a Transgenic Amyotrophic Lateral Sclerosis ModelAgnese Gugliandolo, Sabrina Giacoppo, Placido Bramanti, et al.Neuroreport|August 12, 2016
Is the Wnt/β-catenin pathway involved in the anti-inflammatory activity of glucocorticoids in spinal cord injury?Rosaliana Libro, Sabrina Giacoppo, Placido Bramanti, et al.Journal of the Neurological Sciences|August 14, 2014
Are natural killer cells involved in multiple sclerosis etiology? Evidences from NKp46/NCR1 receptor modulation in an observational studyMaria Galuppo, Sabrina Giacoppo, Edoardo Sessa, et al.Fitoterapia|November 29, 2016
Target regulation of PI3K/Akt/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosisSabrina Giacoppo, Federica Pollastro, Gianpaolo Grassi, et al.Pageof 5